154 related articles for article (PubMed ID: 14981342)
1. Whole deletion of CYP2A6 gene (CYP2A6AST;4C) and smoking behavior.
Iwahashi K; Waga C; Takimoto T
Neuropsychobiology; 2004; 49(2):101-4. PubMed ID: 14981342
[TBL] [Abstract][Full Text] [Related]
2. Association of CYP2A6 gene deletion with cigarette smoking status in Japanese adults.
Ando M; Hamajima N; Ariyoshi N; Kamataki T; Matsuo K; Ohno Y
J Epidemiol; 2003 May; 13(3):176-81. PubMed ID: 12749606
[TBL] [Abstract][Full Text] [Related]
3. A review of smoking behavior and smokers evidence (chemical modification, inducing nicotine metabolism, and individual variations by genotype: dopaminergic function and personality traits).
Iwahashi K; Aoki J
Drug Chem Toxicol; 2009; 32(4):301-6. PubMed ID: 19793020
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C.
Ariyoshi N; Takahashi Y; Miyamoto M; Umetsu Y; Daigo S; Tateishi T; Kobayashi S; Mizorogi Y; Loriot MA; Stücker I; Beaune P; Kinoshita M; Kamataki T
Pharmacogenetics; 2000 Nov; 10(8):687-93. PubMed ID: 11186131
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between smoking and CYP2A6 gene polymorphisms in A Japanese population.
Zhang X; Amemo K; Ameno S; Iwahashi K; Kinoshita H; Kubota T; Mostofa J; Ijiri I
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2001 Oct; 36(5):486-90. PubMed ID: 11725533
[TBL] [Abstract][Full Text] [Related]
6. Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population.
Oscarson M; McLellan RA; Gullstén H; Yue QY; Lang MA; Bernal ML; Sinues B; Hirvonen A; Raunio H; Pelkonen O; Ingelman-Sundberg M
FEBS Lett; 1999 Apr; 448(1):105-10. PubMed ID: 10217419
[TBL] [Abstract][Full Text] [Related]
7. [The relationship between smoking behavior in young people and CYP2A6 gene polymorphisms, between them and personality traits assessed by NEO-FFI].
Waga C; Iwahashi K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Aug; 41(4):380-6. PubMed ID: 17037346
[TBL] [Abstract][Full Text] [Related]
8. Nicotine metabolism and CYP2A6 allele frequencies in Koreans.
Kwon JT; Nakajima M; Chai S; Yom YK; Kim HK; Yamazaki H; Sohn DR; Yamamoto T; Kuroiwa Y; Yokoi T
Pharmacogenetics; 2001 Jun; 11(4):317-23. PubMed ID: 11434509
[TBL] [Abstract][Full Text] [Related]
9. Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort.
Gambier N; Batt AM; Marie B; Pfister M; Siest G; Visvikis-Siest S
Pharmacogenomics J; 2005; 5(4):271-5. PubMed ID: 15940289
[TBL] [Abstract][Full Text] [Related]
10. CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.
Fukami T; Nakajima M; Sakai H; McLeod HL; Yokoi T
Pharmacogenomics J; 2006; 6(6):401-12. PubMed ID: 16636685
[TBL] [Abstract][Full Text] [Related]
11. A novel duplication type of CYP2A6 gene in African-American population.
Fukami T; Nakajima M; Yamanaka H; Fukushima Y; McLeod HL; Yokoi T
Drug Metab Dispos; 2007 Apr; 35(4):515-20. PubMed ID: 17267622
[TBL] [Abstract][Full Text] [Related]
12. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking.
Malaiyandi V; Goodz SD; Sellers EM; Tyndale RF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1812-9. PubMed ID: 17035386
[TBL] [Abstract][Full Text] [Related]
13. CYP2A6 gene polymorphism and personality traits for NEO-FFI on the smoking behavior of youths.
Waga C; Iwahashi K
Drug Chem Toxicol; 2007; 30(4):343-9. PubMed ID: 17934923
[TBL] [Abstract][Full Text] [Related]
14. Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms.
Minematsu N; Nakamura H; Furuuchi M; Nakajima T; Takahashi S; Tateno H; Ishizaka A
Eur Respir J; 2006 Feb; 27(2):289-92. PubMed ID: 16452582
[TBL] [Abstract][Full Text] [Related]
15. The CYP2A6*4 allele is determinant of S-1 pharmacokinetics in Japanese patients with non-small-cell lung cancer.
Kaida Y; Inui N; Suda T; Nakamura H; Watanabe H; Chida K
Clin Pharmacol Ther; 2008 Apr; 83(4):589-94. PubMed ID: 18212800
[TBL] [Abstract][Full Text] [Related]
16. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.
Schoedel KA; Hoffmann EB; Rao Y; Sellers EM; Tyndale RF
Pharmacogenetics; 2004 Sep; 14(9):615-26. PubMed ID: 15475735
[TBL] [Abstract][Full Text] [Related]
17. Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population.
Tan W; Chen GF; Xing DY; Song CY; Kadlubar FF; Lin DX
Int J Cancer; 2001 Mar; 95(2):96-101. PubMed ID: 11241319
[TBL] [Abstract][Full Text] [Related]
18. Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema.
Minematsu N; Nakamura H; Iwata M; Tateno H; Nakajima T; Takahashi S; Fujishima S; Yamaguchi K
Thorax; 2003 Jul; 58(7):623-8. PubMed ID: 12832682
[TBL] [Abstract][Full Text] [Related]
19. CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians.
Vasconcelos GM; Struchiner CJ; Suarez-Kurtz G
Pharmacogenomics J; 2005; 5(1):42-8. PubMed ID: 15534625
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of cytochrome P450 2A6*1A alleles in a black African population of Ghana.
Gyamfi MA; Fujieda M; Kiyotani K; Yamazaki H; Kamataki T
Eur J Clin Pharmacol; 2005 Feb; 60(12):855-7. PubMed ID: 15660270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
